Dubois, Pierre and Magnac, Thierry (2024) Optimal Intertemporal Curative Drug Expenses: The Case of Hepatitis C in France. Journal of Health Economics, vol. 94 (n° 102861). pp. 1-17.

Conte, Bruno, Piemontese, Lavinia and Tapsoba, Augustin (2023) The power of markets: Impact of desert locust invasions on child health. Journal of Health Economics, vol.87.

Cremer, Helmuth and Lozachmeur, Jean-Marie (2022) Coinsurance vs. copayments: reimbursement rules for a monopolistic medical product with competitive health insurers. Journal of Health Economics, vol. 84 (n° 102642). pp. 1-11.

Hammitt, James K. (2022) Prevention, treatment, and palliative care: The relative value of health improvements under alternative evaluation frameworks. Journal of Health Economics, vol.84.

Herrera Araujo, Daniel Andres, Rheinberger, Christoph M. and Hammitt, James K. (2022) Valuing non-marginal changes in mortality and morbidity risk. Journal of Health Economics, vol. 84 (n° 102627).

Adler, Matthew, Ferranna, Maddalena, Hammitt, James K. and Treick, Nicolas (2021) Fair innings? The utilitarian and prioritarian value of risk reduction over a whole lifetime. Journal of Health Economics, vol. 75. pp. 1-59.

Carrieri, Vincenzo, Madio, Leonardo and Principe, Francesco (2020) Do-It-Yourself medicine? The impact of light cannabis liberalization on prescription drugs. Journal of Health Economics (74).

Bardey, David, De Donder, Philippe and Mantilla, Cesar (2019) How is the Trade-off between Adverse Selection and Discrimination Risk Affected by Genetic Testing? Theory and Experiment. Journal of Health Economics, 68. p. 102223.

Bardey, David and Buitrago, Giancarlo (2017) Supplemental health insurance in the Colombian managed care system: Adverse or advantageous selection? Journal of Health Economics, 56. pp. 317-329.

Cremer, Helmuth, Goulão, Catarina and Roeder, Kerstin (2016) Earmarking and the political support of fat taxes. Journal of Health Economics, 50. pp. 258-267.

Cremer, Helmuth, Lozachmeur, Jean-Marie and Pestieau, Pierre (2016) The design of long term care insurance contracts. Journal of Health Economics, 50. pp. 330-339.

Réquillart, Vincent, Soler, Louis-Georges and Zang, Yu (2016) Quality standards versus nutritional taxes: Health and welfare impacts with strategic firms. Journal of Health Economics, 50. pp. 268-285.

Rheinberger, Christoph M., Herrera Araujo, Daniel Andres and Hammitt, James K. (2016) The value of disease prevention vs treatment. Journal of Health Economics, 50. pp. 247-255.

Bardey, David, Jullien, Bruno and Lozachmeur, Jean-Marie (2016) Health insurance and diversity of treatment. Journal of Health Economics, 47. pp. 50-63.

Adler, Matthew, Hammitt, James K. and Treich, Nicolas (2014) The social value of mortality risk reduction: The VSL versus the social welfare function approach. Journal of Health Economics, 35. pp. 82-93.

Rheinberger, Christoph M. and Hammitt, James K. (2014) The Welfare Value of FDA’s Mercury-in-Fish Advisory: A Dynamic Reanalysis. Journal of Health Economics, vol. 37. pp. 113-122.

Bardey, David and De Donder, Philippe (2013) Genetic testing with primary prevention and moral hazard. Journal of Health Economics, 32 (n°5). pp. 768-779.

Bardey, David, Canta, Chiara and Lozachmeur, Jean-Marie (2012) The regulation of health care providers' payments when horizontal and vertical differentiation matter. Journal of Health Economics, 31 (5). pp. 691-704.

Bardey, David, Bommier, Antoine and Jullien, Bruno (2010) Retail Price Regulation and Innovation: Reference Pricing in the Pharmaceutical Industry. Journal of Health Economics, 29 (n°2). pp. 303-316.

Andersson, Henrik and Lundborg, Petter (2008) Gender, Risk Perceptions, and Smoking Behavior. Journal of Health Economics, 27 (5). pp. 1299-1311.